Skip to main content
Premium Trial:

Request an Annual Quote

MGI Tech, Agilent to Integrate Sequencing Platforms, Lab Information Management Solution

NEW YORK – Agilent Technologies and MGI Tech plan to integrate Agilent's laboratory information management system and MGI's sequencing platforms, the companies said yesterday.

Under a collaboration agreement signed last month at the 14th International Conference on Genomics in China, the firms plan to put together Agilent's SLIMS laboratory information system and MGI's DNBSeq series of sequencing platforms and other life science instruments to achieve a seamless connection between hardware and software.

The Agilent SLIMS combines the functions of a lab information management system and an electronic lab record, including electronic lab notebooks, sample management, workflow management, order management, and data display boards.

DNBSeq is the core technology that powers MGI's various sequencing instruments, including DNA single-chain circularization and DNA nanoball preparation, patterned array slides, DNB loading, combinatorial probe anchor synthesis, paired-end sequencing, and base calling algorithms.

Both companies have tested the integration of their systems in MGI's laboratory in Australia through a collaboration that commenced in 2017.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.